Tenmile

Tin Alley Ventures is a venture capital investment firm based in Melbourne, Australia, founded in 2022. The firm focuses on investing in technology startups at various stages, including seed, early, and later stages. It collaborates closely with companies and researchers within the University of Melbourne's ecosystem, aiming to support and develop businesses that have the potential to create significant social and economic impact. Through its strategic partnerships and investment approach, Tin Alley Ventures seeks to foster innovation and drive growth in the technology sector.

Emyria Limited is a healthcare technology and services company based in West Leederville, Australia. Founded in 2018, it operates a network of specialist medical clinics that provide patient-focused treatments, including cannabinoid-based medicines. Emyria is committed to advancing treatment development and enhancing patient care through data-driven approaches. The company has also established a partnership with Mind Medicine Australia to co-develop a clinical model for the safe provision of psychedelic-assisted therapies in Australia. Emyria, previously known as Emerald Clinics Limited, reflects a dedication to innovative healthcare solutions and evidence-based practices.

Mindset Health is a digital therapeutics company offering a mobile platform that delivers app-based hypnotherapy and psychotherapy to help people manage irritable bowel syndrome and other chronic conditions. The platform can treat IBS without dietary changes, improve sleep, and reduce anxiety, stress, and pain related to chronic conditions, providing a rapid, cost-effective, nonaddictive, and safe alternative to traditional care. Based in Melbourne, Australia, Mindset Health focuses on accessible digital therapies that complement conventional treatment and support mental and physical well-being.

Inventia Life Science Pty Ltd is an Australian company founded in 2013 and based in Alexandria. It specializes in 3D bioprinting technology aimed at enhancing cell-based research and clinical applications. The company develops, manufactures, and sells equipment, reagents, and bio-inks—both natural and synthetic—designed for advanced medical research. Inventia's innovative approach focuses on creating low-cost and standardized methods for producing three-dimensional human tissue and organ models. This technology is intended to accelerate cancer research, drug discovery, and advancements in regenerative medicine. By providing a comprehensive suite of hardware, software, consumables, and customized protocols, Inventia Life Science facilitates the flexible production of 3D cell-based assays, significantly impacting the medical research landscape.